Mercer Global Advisors
LXEO icon

Mercer Global Advisors’s Lexeo Therapeutics LXEO Stock Holding History

Mercer Global Advisors’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.9K Buy
+4,915
New +$26.6K ﹤0.01% 4753

Other funds holding LXEO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mercer Global Advisors's LXEO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Lexeo Therapeutics (LXEO) in Q2 2026: 4,915 shares worth $22.9K. The stake represents ﹤0.01% of the portfolio and ranks #4753 among its holdings.

110 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Mercer Global Advisors held 4,915 shares of Lexeo Therapeutics worth $22.9K as of Q2 2026.
  • Lexeo Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4753 holding.
  • 110 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.